RNAi – A powerful tool to unravel hepatitis C virus–host interactions within the infectious life cycle  Joachim Lupberger, Laurent Brino, Thomas F. Baumert 

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Laurent Mailly, Mirjam B. Zeisel, Thomas F. Baumert 
Volume 63, Issue 1, Pages (July 2015)
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Jean Dubuisson, François-Loïc Cosset  Journal of Hepatology 
Inflammasomes in liver diseases
Volume 65, Issue 1, Pages S2-S21 (October 2016)
Volume 50, Issue 4, Pages (April 2009)
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Mirjam B. Zeisel, Isabel Fofana, Samira Fafi-Kremer, Thomas F. Baumert 
The impact of hepatitis E in the liver transplant setting
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 52, Issue 3, Pages (March 2010)
NS5A inhibitors in the treatment of hepatitis C
Hepatitis C-associated B-cell non-Hodgkin lymphomas
Immigration and viral hepatitis
Volume 66, Issue 1, Pages 1-4 (January 2017)
Heidi Barth, Eric Robinet, T. Jake Liang, Thomas F. Baumert 
Endoplasmic reticulum stress in liver disease
Hepatitis C virus entry and glucocorticosteroids
Living donor liver transplantation: is the hype over?
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Mechanisms of HBV-related hepatocarcinogenesis
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study.
Volume 68, Issue 3, Pages (March 2018)
A dive into the complexity of type I interferon antiviral functions
Volume 44, Issue 2, Pages (February 2006)
Inhibition of mammalian target of rapamycin: Two goals with one shot?
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Daniel J. Felmlee, Thomas F. Baumert  Journal of Hepatology 
Volume 62, Issue 3, Pages (March 2015)
Ribavirin ante portas: Uptake transporters into hepatocytes dissected
Genomic risk of hepatitis C-related hepatocellular carcinoma
Hepatitis C virus–cell interactions and their role in pathogenesis
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Advancing hepatitis B virus entry inhibitors
Autophagy in the liver Journal of Hepatology
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
Host-targeting agents for prevention and treatment of chronic hepatitis C – Perspectives and challenges  Mirjam B. Zeisel, Joachim Lupberger, Isabel Fofana,
Therapeutic editing of hepatocyte genome in vivo
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 61, Issue 1, Pages S45-S57 (November 2014)
Mona Malz, Federico Pinna, Peter Schirmacher, Kai Breuhahn 
Interferon-Free Treatment Regimens for Hepatitis C: Are We There Yet?
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Volume 50, Issue 4, Pages (April 2009)
Fei Xiao, Jane A. McKeating, Thomas F. Baumert  Journal of Hepatology 
Paul C. Adams, James C. Barton  Journal of Hepatology 
miR-122 – A key factor and therapeutic target in liver disease
Immigration and viral hepatitis
HCV targeting of patients with cirrhosis
Immunological techniques in viral hepatitis
Innate immunity and HCV
Volume 63, Issue 1, Pages (July 2015)
Jean Dubuisson, François-Loïc Cosset  Journal of Hepatology 
HCV animal models and liver disease
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Eric Robinet, Thomas F. Baumert  Journal of Hepatology 
Genetics of hepatocellular carcinoma: The next generation
Philippe Metz, Antje Reuter, Silke Bender, Ralf Bartenschlager 
Mirjam B. Zeisel, Marine Turek, Thomas F. Baumert 
Presentation transcript:

RNAi – A powerful tool to unravel hepatitis C virus–host interactions within the infectious life cycle  Joachim Lupberger, Laurent Brino, Thomas F. Baumert  Journal of Hepatology  Volume 48, Issue 3, Pages 523-525 (March 2008) DOI: 10.1016/j.jhep.2007.12.007 Copyright © 2007 European Association for the Study of the Liver Terms and Conditions

Fig. 1 HCV–host interactions with functional impact on the HCV life cycle investigated by Randall et al. using RNAi [5]. The putative HCV life cycle including entry, uncoating, translation, polyprotein processing, replication, assembly and export is shown in blue. Examples of cellular cofactors with a functional impact on the HCV infection in the HCV tissue culture system [5] are depicted in relationship to the respective steps of the viral life cycle. Gene abbreviations refer to Human Genome Organization nomenclature (HUGO): NF-κB, nuclear factor of kappa light chain gene enhancer in B-cells; PTBP1, polypyrimidine tract binding protein 1; miR-122, microRNA type 122; HSP70, heat shock protein 70kDa; ATF6, activating transcription factor 6; RAF1, v-raf-1 murine leukemia viral oncogene homolog 1; ACTN1, actinin alpha 1; VAP-A/B, vesicle-associated membrane protein A and B. Journal of Hepatology 2008 48, 523-525DOI: (10.1016/j.jhep.2007.12.007) Copyright © 2007 European Association for the Study of the Liver Terms and Conditions